These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4753373)

  • 1. [Xeroderma pigmentosum, universal alopecia and associated neuro-ocular symptoms].
    Diem E; Fritsch P
    Hautarzt; 1973 May; 24(5):204-7. PubMed ID: 4753373
    [No Abstract]   [Full Text] [Related]  

  • 2. 5 FU in the treatment of Xeroderma pigmentosum.
    Kint A; Kint RT; Schuddinck L
    Arch Belg Dermatol Syphiligr; 1972; 28(3):263-6. PubMed ID: 4664707
    [No Abstract]   [Full Text] [Related]  

  • 3. Xeroderma pigmentosum.
    Zeligman I; Lutzner MA; Scott CI
    Birth Defects Orig Artic Ser; 1971 Jun; 7(8):296-7. PubMed ID: 5173292
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum.
    Kim J; Savory SA; Demehri S; Gill JG
    JAMA Dermatol; 2023 Feb; 159(2):226-227. PubMed ID: 36542363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Xeroderma pigmentosum: prevention of tumors with etretinate].
    Pichler E; Fritsch P
    Hautarzt; 1984 Mar; 35(3):159-61. PubMed ID: 6715172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular manifestations of xeroderma pigmentosum (report of 5 cases)].
    Ben Rayana N; Ruhomauly H; Limaiem R; Mahjoub H; Ben Hadj Hamida F
    Tunis Med; 1998; 76(8-9):263-7. PubMed ID: 9810864
    [No Abstract]   [Full Text] [Related]  

  • 7. [External treatment with 5-fluorouracil].
    Swart-Bruinsma WA; Herrmann WA
    Ned Tijdschr Geneeskd; 1973 Jul; 117(30):1115-8. PubMed ID: 4784361
    [No Abstract]   [Full Text] [Related]  

  • 8. [Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 49 Tunisian cases].
    Zghal M; El-Fekih N; Fazaa B; Fredj M; Zhioua R; Mokhtar I; Mrabet A; Ferjani M; Gaigi S; Kamoun MR
    Tunis Med; 2005 Dec; 83(12):760-3. PubMed ID: 16450945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
    Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
    Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melanoma in xeroderma pigmentosum: 12 cases].
    Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
    Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ophtalmologic manifestations of the xeroderma pigmentosum].
    Mseddi M; Sellami D; Elloumi Y; Aloulou Y; Kammoun B; Turki H; Feki J; Zahaf A
    Tunis Med; 2006 Sep; 84(9):542-4. PubMed ID: 17263199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of xeroderma pigmentosum with ocular manifestations].
    Perron R; Duverne J; Guerin JC
    Bull Soc Ophtalmol Fr; 1968 Apr; 68(4):520-2. PubMed ID: 5759315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Xeroderma pigmentosum complicated with brain symptoms].
    Noto C; Kamoya M; Hoshi J; Aoki K
    Seishin Shinkeigaku Zasshi; 1967 Jun; 69(6):539-44. PubMed ID: 5625388
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical enzyme therapy for skin diseases?
    Kraemer KH; DiGiovanna JJ
    J Am Acad Dermatol; 2002 Mar; 46(3):463-6. PubMed ID: 11862191
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular findings in xeroderma pigmentosum: report of two cases.
    Stenson S
    Ann Ophthalmol; 1982 Jun; 14(6):580-5. PubMed ID: 7114695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorouracil cream (Efudix) in dermatology.
    Drug Ther Bull; 1973 Nov; 11(24):94-6. PubMed ID: 4771790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum].
    Boussen H; Zwik J; Mili-Boussen I; Rammeh N; Bouaouina N; Gritli S; el May A; Kammoun MR; Ouertani A; Ladgham A
    Therapie; 2001; 56(6):751-4. PubMed ID: 11878102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum. Treatment with topically applied fluorouracil.
    Carter VH; Smith KW; Noojin RO
    Arch Dermatol; 1968 Nov; 98(5):526-7. PubMed ID: 5684229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular malignancies of xeroderma pigmentosum: clinical and therapeutic features].
    Touzri RA; Mohamed Z; Khalil E; Ilhem MB; Insaf M; Bassima F; Amel MO
    Ann Dermatol Venereol; 2008 Feb; 135(2):99-104. PubMed ID: 18342089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular involvement in xeroderma pigmentosum.
    Gulati GC; Ahluwalia BK
    J All India Ophthalmol Soc; 1967 Dec; 15(6):233-5. PubMed ID: 5618279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.